Inactive Instrument

News Osiris Therapeutics, Inc.

Equities

US68827R1086

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc	19-04-17	GL
WeissLaw LLP Investigates Osiris Therapeutics, Inc.	19-03-15	PR
Johnson & Johnson : Smith & Nephew to buy Osiris in regenerative products push	19-03-12	RE
Osiris Therapeutics : Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.	19-03-12	PR
Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc	19-03-12	GL
Hagens Berman: Notice to Osiris Therapeutics, Inc. Investors: Less than One Week Left to File Claims to Receive Part of $18.5 Million Settlement	19-01-24	BU
Osiris Therapeutics : Hagens Berman Notifies Osiris Therapeutics, Inc. Investors of Class Action Settlement and January 30, 2019 Claims Deadline	19-01-15	BU
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer	18-11-26	GL
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results	18-11-07	GL
Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO	18-02-06	GL
Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation	17-11-02	GL
Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statements	17-10-30	GL
Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane	17-10-23	GL
Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology	17-10-19	GL
Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin	17-10-05	GL
Osiris Appoints Linda Palczuk to serve as its President & CEO	17-06-26	GL
Osiris Announces Electronically Available Case Study in a Peer-Reviewed Journal: Open Surgical Implantation of a Viable Cryopreserved Placental Membrane after Decompression and Neurolysis of Common Peroneal Nerve	17-06-14	GL
Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal	17-04-13	GL
Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology	17-04-04	GL
Osiris Therapeutics Announces Change in its Board of Directors	17-03-31	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Osiris Therapeutics, Inc.

Equities

US68827R1086

Summary

Filters